Get more replies from employers
Send a job-specific resume in minutes.
Bill & Melinda Gates Foundation is seeking a senior leader to refine and advance the TB Diagnostics R&D strategy. You will manage a high-impact portfolio, guiding scientific, technical, and partnership aspects of diagnostics development, with close collaboration to EDGE and TB/HIV teams.
The role drives innovation in low- and middle-income country settings and reports to the Deputy Director of TB Drugs & Diagnostics R&D.
We are the largest nonprofit fighting poverty, disease, and inequity around the world. Founded on a simple premise: people everywhere, regardless of identity or circumstances, should have the chance to live healthy, productive lives. We believe our employees should reflect the rich diversity of the global populations we aim to serve. We provide an exceptional benefits package to employees and their families which include comprehensive medical, dental, and vision coverage with no premiums, generous paid time off, paid family leave, foundation-paid retirement contribution, regional holidays, and opportunities to engage in several employee communities. As a workplace, we're committed to creating an environment for you to thrive both personally and professionally.
Our Global Health (GH) division harnesses advances in science and technology to save lives in developing countries. We focus on the health problems that have a major impact in developing countries but get too little attention and funding. Where tools exist, we support sustainable ways to improve their delivery. Where they don't, we invest in research and development of new interventions, such as vaccines, drugs, and diagnostics. Our work in infectious diseases focuses on strategies to fight and prevent HIV/AIDS, malaria, tuberculosis (TB), neglected tropical diseases, enteric and diarrheal diseases, pneumonia and maternal, newborn and child health. Our TB and HIV work is combined under a joint TB/HIV Program Strategy Team (PST) which focuses on research, development and delivery of new products and tools. The goal of the tuberculosis (TB) Program Strategy is to accelerate the reduction in TB incidence globally through innovative discovery and development of new tools and approaches. The TB Program Strategy Team (PST) is responsible for research and development (R&D) investments targeting more effective TB interventions including vaccines, diagnostics, and drugs. The HIV team's strategic vision is to accelerate the reduction in the incidence of HIV infection in high-burden geographies and populations, with a focus on the development of new prevention and treatment interventions, including long-acting drugs, vaccines and biologics, and to enable their effective use. Accessible, low-cost, high-quality diagnostics are essential for early TB detection and for the success of any improved TB treatment regimen. The TB Diagnostics R&D portfolio focuses on near-point-of-care (nPOC) tests, distributable PCR kits, and affordable screening tools to expand testing and enable same-visit treatment initiation. HIV Diagnostics are an integral part of our planning for the effective introduction of novel long-acting prevention and treatment regimens. We work in close partnership with the Enterics, Diagnostics, Genomics & Epidemiology (EDGE) and TB/HIV Delivery teams to define and manage a research and development portfolio of TB diagnostics and devices.
Application Deadline: Friday, August 28, 2026
You will be primarily responsible for refining, informing and advancing the TB Diagnostics R&D strategy through the shaping and management of a portfolio of high-impact investments aimed at accelerating the development, and validation of novel TB diagnostics and diagnostic devices for use in low-and-middle-income countries (LMICs). You will work in close partnership with the EDGE (Enterics, Diagnostics, Genomics & Surveillance) and TB Delivery teams to guide scientific, technical, and partnership aspects of the diagnostics development pipeline and ensure alignment with the foundation's TB diagnostics introduction goals. You will also collaborate with the HIV team to refine the HIV Diagnostics strategy and define potential high value HIV diagnostics investments designed to advance the foundation's HIV product introduction priorities. Together the role includes contributing to strategy formulation, managing complex grants and contracts, engaging with a diverse set of partners, and staying at the forefront of innovation and trends in diagnostics technologies. You will report to the Deputy Director of TB Drugs & Diagnostics R&D.
The salary range for this role is $212,800 to $329,800 USD. We recognize high-wage market differences in Seattle and Washington D.C., where our offices are located. The range for this role in these locations is $234,000 to $362,800 USD.
As part of our standard hiring process for new employees, employment will be contingent upon successful completion of a background check.
We are dedicated to the belief that all lives have equal value. We strive for a global and cultural workplace that supports ever greater diversity, equity, and inclusion - of voices, ideas, and approaches - and we support this diversity through all our employment practices. All applicants and employees who are drawn to serve our mission will enjoy equality of opportunity and fair treatment without regard to race, color, age, religion, pregnancy, sex, sexual orientation, disability, gender identity, gender expression, national origin, genetic information, veteran status, marital status, and prior protected activity. Guided by the belief that every life has equal value, the Gates Foundation works to help all people lead healthy, productive lives. In developing countries, we work with partners to create impactful solutions so that people can take charge of their futures and achieve their full potential. In the United States, we aim to ensure that everyone - especially those with the fewest resources - has access to the opportunities needed to succeed in school and life. Based in Seattle, Washington, the foundation is led by CEO Mark Suzman, under the direction of Bill Gates and our governing board.